ONCOMINE data showed that in addition to CXCL1, CXCL4, CXCL11 and CXCL12, the mRNA levels of the other 12 CXC chemokines were significantly increased in pancreatic cancer (Fig. 1A). This evidence concerns the gene CXCL12 and pancreatic neoplasm.